RNAi-mediated inhibition of ocular targets

Details for Australian Patent Application No. 2006210846 (hide)

Owner Alcon, Inc.

Inventors Chatterton, Jon E.; Wax, Martin B.; Clark, Abbot F.; Shepard, Allan R.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006210846

PCT Pub. Number WO2006/083945

Priority 60/648,926 01.02.05 US; 60/753,364 22.12.05 US

Filing date 1 February 2006

Wipo publication date 10 August 2006

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/083945 Priority application(s): WO2006/083945

25 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210847-Method and device for selective addition of a bioactive agent to a multiphase implant

2006210845-Real-time image detection using polarization data